Thirumalai Chemicals · NSE: TIRUMALCHM · BSE: 500412
Q3 FY26 results · Oct–Dec 2025
Thirumalai Chemicals reported revenue from operations of ₹415.85 crore (down 6.9% from Q3 FY25) and net loss of ₹46.57 crore for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 415.85 | 446.65 | −6.9% | 445.37 | −6.6% |
| Other income | 3.97 | 0.20 | 20x | 8.39 | −52.7% |
| Total income | 419.82 | 446.85 | −6.0% | 453.76 | −7.5% |
| Profit before tax | (55.26) | (49.91) | Loss widened | (43.77) | Loss widened |
| Net profit for the period | (46.57) | (42.02) | Loss widened | (33.38) | Loss widened |
| EPS, basic (₹) | (3.92) | (4.10) | not comparable | (3.07) | Loss widened |
| Net margin (%) | -11.2 | -9.4 | -7.5 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 300.27 | 498.26 | −39.7% | 357.01 | −15.9% |
| Other income | 7.20 | 5.28 | +36.4% | 14.86 | −51.5% |
| Total income | 307.47 | 503.54 | −38.9% | 371.87 | −17.3% |
| Profit before tax | (36.09) | (11.72) | Loss widened | (17.52) | Loss widened |
| Net profit for the period | (27.42) | (8.45) | Loss widened | (13.32) | Loss widened |
| EPS, basic (₹) | (2.31) | (0.83) | not comparable | (1.22) | Loss widened |
| Net margin (%) | -9.1 | -1.7 | -3.7 |
Consolidated
- Filed with BSE
- 14 Feb 2026, 18:08 IST
- Board meeting
- 14 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Feb 2026, 18:08 IST
- Board meeting
- 14 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE